Development of a qualitative sequential immunoassay for characterizing the intrinsic properties of circulating cardiac troponin I

Clinical Chemistry

Volumn 56, Issue 8, 2010, Pages 1307-1319

  Lin, Yixin ^a   Fu, Qin ^b   Zhu, Jie ^b   Miller, Julie M ^b   Van Eyk, Jennifer E ^b,c  

^a Axela Inc   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; MONOCLONAL ANTIBODY; TROPONIN I; TROPONIN T;

ARTICLE; CONTROLLED STUDY; DIFFRACTION; HEART INFARCTION; HUMAN; IMMUNOASSAY; IMMUNODETECTION; MEDICAL TECHNOLOGY; OPTICS; PHOSPHORYLATION; PROTEIN STRUCTURE; QUALITATIVE ANALYSIS; SENSOR; SERUM; WESTERN BLOTTING;

HUMANS; IMMUNOASSAY; MULTIPROTEIN COMPLEXES; MYOCARDIAL INFARCTION; PHOSPHORYLATION; REPRODUCIBILITY OF RESULTS; TROPONIN C; TROPONIN I; TROPONIN T;

EID: 77955256134     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.135186     Document Type: Article

References (38)

1. Gaze DC, Collinson PO. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem 2008;45: 349-55.
2. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
3. Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53:2086-96.
4. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. It's time for a change to a troponin standard. Circulation 2000;102: 1216-20.
5. McDonough JL, Van Eyk JE. Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog Cardiovasc Dis 2004;47:207-16.
6. Van Eyk JE, Murphy AM. The role of troponin abnormalities as a cause for stunned myocardium. Coron Artery Dis 2001;12:343-7.
7. Solaro RJ, Van Eyk J. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 1996;28:217-30. (Pubitemid 26110467)
8. Solaro RJ, Rosevear P, Kobayashi T. The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun 2008;369:82-7.
9. McDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 1999;84:9-20.
10. McDonough JL, Labugger R, Pickett W, Tse MY, MacKenzie S, Pang SC, et al. Cardiac troponin I is modified in the myocardium of bypass patients. Circulation 2001;103:58-64. (Pubitemid 32050436)
11. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000;102:1221-6.
12. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JMJ. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001;103:2035-7. (Pubitemid 32373003)
13. Labugger R, Simpson JA, Quick M, Brown HA, Collier CE, Neverova I, Van Eyk JE. Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem 2003;49: 873-9.
14. Madsen LH, Christensen G, Lund T, Serebruany VL, Granger CB, Hoen I, et al. Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res 2006;99: 1141-7. (Pubitemid 44729939)
15. Peronnet E, Becquart L, Poirier F, Cubizolles M, Choquet-Kastylevsky G, Jolivet-Reynaud C. SELDI-TOF MS analysis of the cardiac troponin I forms present in plasma from patients with myocardial infarction. Proteomics 2006;6:6288-99. (Pubitemid 44935515)
16. Zabrouskov V, Ge Y, Schwartz J, Walker JW. Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry. Mol Cell Proteomics 2008;7:1838-49.
17. Giuliani I, Bertinchant JP, Lopez M, Coquelin H, Granier C, Laprade M, et al. Determination of cardiac troponin I forms in the blood of patients with unstable angina pectoris. Clin Biochem 2002;35:111-7. (Pubitemid 34442690)
18. Giuliani I, Bertinchant JP, Granier C, Laprade M, Chocron S, Toubin G, et al. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia. Clin Chem 1999;45:213-22. (Pubitemid 29079119)
19. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lovgren T, Severina ME, et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379-85. (Pubitemid 27329785)
20. Wu AH, Feng Y, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998;44: 1198-208. (Pubitemid 28283057)
21. Peronnet E, Becquart L, Martinez J, Charrier JP, Jolivet-Reynaud C. Isoelectric point determination of cardiac troponin I forms present in plasma from patients with myocardial infarction. Clin Chim Acta 2007;377:243-7. (Pubitemid 44908259)
22. Loo RW, Tam PL, Goh JB, Goh MC. An enzyme-amplified diffraction-based immunoassay. Anal Biochem 2005;337:338-42.
23. Borisenko V, Hu W, Tam P, Chen I, Houle JF, Ausserer W. Diffractive optics technology: a novel detection technology for immunoassays. Clin Chem 2006;52:2168-72.
24. Van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ. Breakdown and release of myofilament proteins during ischemia and ischemia/ reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res 1998;82:261-71. (Pubitemid 28080109)
25. Bovenkamp DE, Stanley BA, Van Eyk JE. Optimization of cardiac troponin I pull-down by IDM affinity beads and SELDI. Methods Mol Biol 2007; 357:91-102.
26. Foster DB, Noguchi T, VanBuren P, Murphy AM, Van Eyk JE. C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. Circ Res 2003;93:917-24. (Pubitemid 37433229)
27. Narolska NA, Piroddi N, Belus A, Boontje NM, Scellini B, Deppermann S, et al. Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ Res 2006;99:1012-20. (Pubitemid 44657805)
28. Lequin RM. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem 2005;51:2415-8.
29. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA): quantitative assay of immunoglobulin G. Immunochemistry 1971;8: 871-4.
30. Jonsson U, Fagerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundh K, et al. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. BioTechniques 1991;11:620-7.
31. Karlsson R. SPR for molecular interaction analysis: a review of emerging application areas. J Mol Recognit 2004;17:151-61. (Pubitemid 38688875)
32. Karlsson R, Michaelsson A, Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods 1991;145:229-40.
33. Phillips KS, Cheng Q. Recent advances in surface plasmon resonance based techniques for bio-analysis. Anal Bioanal Chem 2007;387:1831-40. (Pubitemid 46309549)
34. Karlsson R. Affinity analysis of non-steady-state data obtained under mass transport limited conditions using BIAcore technology. J Mol Recognit 1999;12:285-92. (Pubitemid 129708591)
35. Malmqvist M. Biospecific interaction analysis using biosensor technology. Nature 1993;361: 186-7.
36. Karlsson R, Roos H, Fägerstam P, Persson B. Kinetic and concentration analysis using BIA technology. Methods (Orlando) 1993;6:99-110.
37. Ferrieres G, Calzolari C, Mani JC, Laune D, Trinquier S, Laprade M et al. Human cardiac troponin I: precise identification of antigenic epitopes and prediction of secondary structure. Clin Chem 1998;44:487-93. (Pubitemid 28141342)
38. Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K, et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998;44: 2433-40. (Pubitemid 28565654)